Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shengying Lou

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Current Medicinal Chemistry|September 13, 2021
Drug Treatment of Epilepsy: From Serendipitous Discovery to Evolutionary MechanismsShengying Lou, Sunliang Cui
Current Medicinal Chemistry|February 4, 2024
Targeting NLRP3 Inflammasome: Structure, Function, and InhibitorsShengying Lou, Miaolian Wu, Sunliang Cui
Renal Failure|November 3, 2025
Cost-effectiveness of combining finerenone and sodium-glucose cotransporter 2 inhibitors with standard of care for patients with chronic kidney disease and type 2 diabetes in ChinaZhengqiang Hu, Wei Jin, Shengying Lou, et al.
Bioorganic & Medicinal Chemistry Letters|May 17, 2022
Discovery of (2-phenylthiazol-4-yl)urea derivatives that induce neuronal differentiation from mesenchymal stem cellsShengying Lou, Ting Huang, Jifeng Qi, et al.
Biochemical and Biophysical Research Communications|November 4, 2025
Antibacterial and anti-biofilm activity of kushenol N against methicillin-resistant Staphylococcus aureusChunyan Dai, Shengying Lou, Xiangcheng Fan, et al.
Journal of Medicinal Chemistry|September 26, 2022
Discovery of 2-(1-(3-Chloro-4-cyanophenyl)-1<i>H</i>-pyrazol-3-yl)acetamides as Potent, Selective, and Orally Available Antagonists Targeting the Androgen ReceptorChangwei Chen, Xin Chai, Xueping Hu, et al.
European Journal of Medicinal Chemistry|February 12, 2025
Discovery of naphthoquinone-furo-piperidone derivatives as dual targeting agents of STAT3 and NQO1 for the treatment of breast cancerShengying Lou, Chenjun Shen, Hao Ni, et al.
Journal of Medicinal Chemistry|February 22, 2022
Discovery of Novel Indazoles as Potent and Selective PI3Kδ Inhibitors with High Efficacy for Treatment of Hepatocellular CarcinomaJifeng Qi, Weihua Wang, Yongmei Tang, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|September 20, 2025
Nordihydroguaiaretic acid (NDGA) exhibits potent anti-biofilm and antimicrobial activity against methicillin-resistant Staphylococcus aureus and Candida albicansXiangcheng Fan, Chunyan Dai, Jichun Han, et al.
European Journal of Pharmacology|April 3, 2025
Corrigendum to "Betulonic acid: A review on its sources, biological activities, and molecular mechanisms" [Eur. J. Pharmacol. 998 (2025) 177518]Shengying Lou, Chunyan Dai, Yuhua Wu, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Current Medicinal Chemistry|September 13, 2021
Drug Treatment of Epilepsy: From Serendipitous Discovery to Evolutionary MechanismsShengying Lou, Sunliang Cui
Current Medicinal Chemistry|February 4, 2024
Targeting NLRP3 Inflammasome: Structure, Function, and InhibitorsShengying Lou, Miaolian Wu, Sunliang Cui
Renal Failure|November 3, 2025
Cost-effectiveness of combining finerenone and sodium-glucose cotransporter 2 inhibitors with standard of care for patients with chronic kidney disease and type 2 diabetes in ChinaZhengqiang Hu, Wei Jin, Shengying Lou, et al.
Bioorganic & Medicinal Chemistry Letters|May 17, 2022
Discovery of (2-phenylthiazol-4-yl)urea derivatives that induce neuronal differentiation from mesenchymal stem cellsShengying Lou, Ting Huang, Jifeng Qi, et al.
Biochemical and Biophysical Research Communications|November 4, 2025
Antibacterial and anti-biofilm activity of kushenol N against methicillin-resistant Staphylococcus aureusChunyan Dai, Shengying Lou, Xiangcheng Fan, et al.
Journal of Medicinal Chemistry|September 26, 2022
Discovery of 2-(1-(3-Chloro-4-cyanophenyl)-1<i>H</i>-pyrazol-3-yl)acetamides as Potent, Selective, and Orally Available Antagonists Targeting the Androgen ReceptorChangwei Chen, Xin Chai, Xueping Hu, et al.
European Journal of Medicinal Chemistry|February 12, 2025
Discovery of naphthoquinone-furo-piperidone derivatives as dual targeting agents of STAT3 and NQO1 for the treatment of breast cancerShengying Lou, Chenjun Shen, Hao Ni, et al.
Journal of Medicinal Chemistry|February 22, 2022
Discovery of Novel Indazoles as Potent and Selective PI3Kδ Inhibitors with High Efficacy for Treatment of Hepatocellular CarcinomaJifeng Qi, Weihua Wang, Yongmei Tang, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|September 20, 2025
Nordihydroguaiaretic acid (NDGA) exhibits potent anti-biofilm and antimicrobial activity against methicillin-resistant Staphylococcus aureus and Candida albicansXiangcheng Fan, Chunyan Dai, Jichun Han, et al.
European Journal of Pharmacology|April 3, 2025
Corrigendum to "Betulonic acid: A review on its sources, biological activities, and molecular mechanisms" [Eur. J. Pharmacol. 998 (2025) 177518]Shengying Lou, Chunyan Dai, Yuhua Wu, et al.
Pageof 2